Umbilical cord blood-derived therapy for preterm lung injury: a systematic review and meta-analysis

医学 支气管肺发育不良 荟萃分析 严格标准化平均差 内科学 临床试验 脐带 相对风险 置信区间 肿瘤科 胎龄 怀孕 免疫学 生物 遗传学
作者
Elisha Purcell,Jainam Shah,Cameron J. Powell,Timothy Nguyen,Lindsay Zhou,Courtney McDonald,Beth J. Allison,Atul Malhotra
出处
期刊:Stem Cells Translational Medicine [Wiley]
卷期号:13 (7): 606-624
标识
DOI:10.1093/stcltm/szae033
摘要

Abstract Introduction Lung injuries, such as bronchopulmonary dysplasia (BPD), remain a major complication of preterm birth, with limited therapeutic options. One potential emerging therapy is umbilical cord blood (UCB)-derived therapy. Objectives To systematically assess the safety and efficacy of UCB-derived therapy for preterm lung injury in preclinical and clinical studies. Methods A systematic search of MEDLINE, Embase, CENTRAL, ClinicalTrials.gov, and WHO International Trials Registry Platform was performed. A meta-analysis was conducted with Review Manager (5.4.1) using a random effects model. Data was expressed as standardized mean difference (SMD) for preclinical data and pooled relative risk (RR) for clinical data, with 95% confidence intervals (CI). Potential effect modifiers were investigated via subgroup analysis. Certainty of evidence was assessed using the GRADE system. Results Twenty-three preclinical studies and six clinical studies met eligibility criteria. Statistically significant improvements were seen across several preclinical outcomes, including alveolarization (SMD, 1.32, 95%CI [0.99, 1.65]), angiogenesis (SMD, 1.53, 95%CI [0.87, 2.18]), and anti-inflammatory cytokines (SMD, 1.68, 95%CI [1.03, 2.34]). In clinical studies, 103 preterm infants have received UCB-derived therapy for preterm lung injury and no significant difference was observed in the development of BPD (RR, 0.93, 95%CI [0.73, 1.18]). Across both preclinical and clinical studies, administration of UCB-derived therapy appeared safe. Certainty of evidence was assessed as “low.” Conclusions Administration of UCB-derived therapy was associated with statistically significant improvements across several lung injury markers in preclinical studies. Early clinical studies demonstrated the administration of UCB-derived therapy as safe and feasible but lacked data regarding efficacy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
满意草丛完成签到,获得积分10
刚刚
枯风晓月发布了新的文献求助10
刚刚
万能图书馆的应助被haozai采纳,获得10
刚刚
安静破茧完成签到,获得积分10
1秒前
活泼山雁完成签到,获得积分10
1秒前
1秒前
ALWAYS完成签到,获得积分10
2秒前
Dingwang发布了新的文献求助10
2秒前
asdfqaz完成签到,获得积分10
2秒前
2秒前
科研通AI6.2的应助被LL采纳,获得30
2秒前
2秒前
EchooOO完成签到,获得积分10
2秒前
小健给小健的求助进行了留言
2秒前
叭叭叭发布了新的文献求助30
2秒前
非酋本酋完成签到,获得积分10
3秒前
Fred Guan完成签到,获得积分10
3秒前
nnn完成签到,获得积分10
3秒前
shirelylee发布了新的文献求助10
3秒前
3秒前
4秒前
悲凉的怜蕾完成签到 ,获得积分10
4秒前
大意的珠完成签到,获得积分20
4秒前
ninomae完成签到 ,获得积分10
4秒前
熊猫小肿完成签到,获得积分10
4秒前
4秒前
云宝宝发布了新的文献求助30
5秒前
跳跃的奎完成签到,获得积分20
5秒前
chenjunan完成签到,获得积分20
5秒前
5秒前
悦耳灰狼完成签到,获得积分10
5秒前
幻想的思绪完成签到,获得积分10
5秒前
6秒前
化合物来发布了新的文献求助10
6秒前
宫城良官完成签到 ,获得积分10
6秒前
6秒前
6秒前
Auraro完成签到,获得积分10
6秒前
快乐觅云完成签到 ,获得积分10
6秒前
cc发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159480
求助须知:如何正确求助?哪些是违规求助? 9554975
关于积分的说明 21723753
捐赠科研通 7749303
什么是DOI,文献DOI怎么找? 3427226
关于科研通互助平台的介绍 2552227
邀请新用户注册赠送积分活动 2471592